Crystalloids Versus Colloids Versus Hypertonic Saline as a Co-load During Spinal Anesthesia.
1 other identifier
interventional
120
1 country
1
Brief Summary
Spinal anesthesia is commonly accompanied by hypotension due to vasodilation that follows sympathetic blockade and decreased systemic vascular resistance. Prevention of hypotension is usually achieved through administration of fluids and vasopressors .There is an ongoing debate concerning both the proper fluid timing, pre-load against co-load and fluid type crystalloids against colloids .This study aims at comparing the effectiveness of co-loading of crystalloids versus colloids versus hypertonic saline 3% in preventing hypotension induced by spinal anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2018
CompletedFirst Submitted
Initial submission to the registry
September 19, 2018
CompletedFirst Posted
Study publicly available on registry
September 24, 2018
CompletedSeptember 24, 2018
September 1, 2018
6 months
September 19, 2018
September 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hypotension
The development of hypotension
3 hours
Secondary Outcomes (1)
serum sodium level
3 hours
Study Arms (3)
normal saline
ACTIVE COMPARATORPatients will receive normal saline 0.9% 15 ml/kg over 15-20 minutes.
Hydroxyethyl starch
ACTIVE COMPARATORPatients will receive hydroxyethyl starch 130/0.4 in 0.9 % sodium chloride 5 ml/kg over 15-20 minutes.
Hypertonic saline
ACTIVE COMPARATORPatients will receive hypertonic saline 3% (7ml/kg) over 15-20 minutes.
Interventions
hydroxyethyl starch 130/0.4 in 0.9 % sodium chloride 5 ml/kg over 15-20 minutes.
Eligibility Criteria
You may qualify if:
- Age 18-65 years
- ASA II-III
- Elective lower abdominal surgeries
You may not qualify if:
- Coagulation defects
- Abnormal kidney or liver functions
- Local infection at site of injection
- Uncontrolled hypertension
- Bone metastases
- Cardiac disease
- Elevated serum sodium level \> 145 mEq/L
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesia and Pain medicine.National Cancer Institute
Cairo, 11796, Egypt
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ehab H Shaker, MD
National Cancer Institute- Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia ,critical care and pain medicine
Study Record Dates
First Submitted
September 19, 2018
First Posted
September 24, 2018
Study Start
February 28, 2018
Primary Completion
August 30, 2018
Study Completion
August 30, 2018
Last Updated
September 24, 2018
Record last verified: 2018-09